Record Year for AACR Annual Meeting 2024: Summary of Cutting-Edge Science and More!
A recap of the plenary sessions, cutting-edge science, clinical trials, and more covered by the AACR blog.
Vemurafenib Becomes First FDA-approved Treatment for a Rare Type of Blood Cancer
Recently, the U.S. Food and Drug Administration (FDA) approved the molecularly targeted therapeutic vemurafenib (Zelboraf) for treating certain adults...
10 Most Popular Cancer Research Catalyst Blog Posts of 2015
It’s that time of year when we reflect on the progress we made over the past 12 months –...
AACR Report Shines Light on Cancer Health Disparities
At the age of 40, Marlena Murphy was diagnosed with triple-negative breast cancer, an aggressive subtype that occurs twice...
Empowering Scholars Worldwide: Celebrating the First Anniversary of the Global Scholar Alumni Committee
The Global Scholar Alumni Committee reflects on their progress after the first year in helping the careers of young...
Cancer Disparities: The Gaps and Encouraging Progress
Insights from the AACR Cancer Disparities Progress Report 2024.
AACR Virtual Annual Meeting I: The Opening Session
In an extraordinary turn of events, the American Association for Cancer Research (AACR) Annual Meeting 2020 kicked off Monday...
The Fuzzy Factor: Striving to Protect Patient Privacy in Big Data Sets
A major objective of former Vice President Joe Biden’s National Cancer Moonshot Initiative is breaking down silos and sharing...
Risky Business: Breast Cancer Risk Factors and What We Know About Them
A look at recent research on determining breast cancer risk, the impact of lifestyle changes on cancer risk, and...
Leading Cancer Experts Comment on the Cancer Initiative in the State of the Union Address
Editor’s Note: Several prominent American Association for Cancer Research (AACR) leaders have shared their reactions to President Obama’s Jan....
AACR Annual Meeting 2021: A Recap of Blog Posts
The AACR Annual Meeting 2021 featured the theme “Discovery Science Driving Clinical Breakthroughs.” Indeed, over the course of two weeks,...
How Can We Use Technology to Advance Population Science Research?
There has been a rapid expansion of technology in recent years, from artificial intelligence to intensive genetic sequencing to...
Experts Forecast Cancer Research and Treatment Advances in 2018
This past year has been a year of many “firsts” for the oncology community, with several revolutionary advances in...
AACR Virtual Annual Meeting I: A Roundup of Cancer Research Catalyst Posts
Just over a month ago, the American Association for Cancer Research (AACR) held the first portion of its Annual...
Addressing the Promise and Challenges of Big Data
Guest post by Hisham Hamadeh, PhD, and Shawn M. Sweeney, PhD Imagine a world where many of the decisions...
What to Know Before Heading to the AACR Annual Meeting 2025
Key details about the program, registration, networking opportunities, and more, to help attendees prepare for the AACR Annual Meeting...
ICYMI: A Recap of Blog Posts From AACR Annual Meeting 2022
From a joyous opening performance from the Preservation Hall All-Stars to a closing plenary that highlighted the full spectrum...
Vice President Joe Biden Speaks at the AACR Annual Meeting 2016
Vice President Joe Biden spoke at the AACR Annual Meeting 2016 about the importance of breaking silos and promoting...
Abstracts
Abstract submission will open on September 28, 2026. The submission deadline is November 10, 2026. New Requirement for Abstract...
Program
Plenary Sessions Presidential Select Symposium Monday, April 20, 2026 Targeting Stage 0: Precision-Based Prevention Chair: Raymond N. Dubois, MUSC...
Forecasting Advances Against Cancer in 2017
Cancer experts discuss the potential breakthroughs in cancer prevention, disparities, precision medicine, and immunotherapy in the coming year. What...
A Targeted Therapy Combination for Colorectal Cancer
The FDA has approved a new combination of molecularly targeted therapeutics for treating metastatic colorectal cancer with a BRAF...
Four New Institutions Join AACR Project GENIE® Consortium
PHILADELPHIA — To further its commitment to diversity, equity, and inclusion, the American Association for Cancer Research (AACR) has...
AACR Project GENIE Begins Five-year Collaborative Research Project with $36 Million in New Funding
The project will further enhance a unique, real-world clinico-genomic dataset through the joint efforts of nine biopharmaceutical companies PHILADELPHIA...
AACR Project GENIE Named a Winner of the 2025 Amazon Web Services Imagine Grant for Nonprofits
AI-powered, multilingual cancer research pipeline will accelerate the pace of global data curation and expand access to real-world clinical...
David R. Parkinson, MD, Honored With the 2026 AACR Outstanding Achievement Award for Service to Cancer Science and Medicine
SAN DIEGO – The 2026 AACR Outstanding Achievement Award for Service to Cancer Science and Medicine will be presented...
Giusti, Pelosi, and Sawyers to Receive American Association for Cancer Research Distinguished Public Service Awards
PHILADELPHIA — The American Association for Cancer Research (AACR) will present Distinguished Public Service Awards to three individuals whose...
Charles L. Sawyers, MD, Elected American Association for Cancer Research Academy President-Elect for 2020-2021
PHILADELPHIA — The Fellows of the American Association for Cancer Research (AACR) have elected Charles L. Sawyers, MD, FAACR,...
AACR Announces Recipients of its 2021 Scientific Achievement Awards and Lectureships
Awardees to be recognized at the virtual AACR Annual Meeting 2021 PHILADELPHIA — The American Association for Cancer Research...
Early-onset Colorectal Cancers from Patients of Different Races May Exhibit Distinct Genetic Features
PHILADELPHIA – Racial differences in genetic mutations were observed among early-onset colorectal cancers (CRC), according to data presented during...